These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 28891454)

  • 1. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Resistance in ESKAPE Pathogens.
    De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESKAPEing the labyrinth of antibacterial discovery.
    Tommasi R; Brown DG; Walkup GK; Manchester JI; Miller AA
    Nat Rev Drug Discov; 2015 Aug; 14(8):529-42. PubMed ID: 26139286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel antibacterial drugs to combat multiple resistant organisms.
    Bassetti M; Righi E
    Langenbecks Arch Surg; 2015 Feb; 400(2):153-65. PubMed ID: 25667169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae.
    Blasco B; Jang S; Terauchi H; Kobayashi N; Suzuki S; Akao Y; Ochida A; Morishita N; Takagi T; Nagamiya H; Suzuki Y; Watanabe T; Lee H; Lee S; Shum D; Cho A; Koh D; Park S; Lee H; Kim K; Ropponen HK; Augusto da Costa RM; Dunn S; Ghosh S; Sjö P; Piddock LJV
    EBioMedicine; 2024 Apr; 102():105073. PubMed ID: 38520916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in antibacterial applications of metal nanoparticles (MNPs) and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria.
    Alavi M; Rai M
    Expert Rev Anti Infect Ther; 2019 Jun; 17(6):419-428. PubMed ID: 31046483
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.
    Garza-González E; Llaca-Díaz JM; Bosques-Padilla FJ; González GM
    Chemotherapy; 2010; 56(4):275-9. PubMed ID: 20693798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.
    Sun W; Weingarten RA; Xu M; Southall N; Dai S; Shinn P; Sanderson PE; Williamson PR; Frank KM; Zheng W
    Emerg Microbes Infect; 2016 Nov; 5(11):e116. PubMed ID: 27826141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense RNA regulation and application in the development of novel antibiotics to combat multidrug resistant bacteria.
    Ji Y; Lei T
    Sci Prog; 2013; 96(Pt 1):43-60. PubMed ID: 23738437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The millennium bugs--the need for and development of new antibacterials.
    Bax R; Mullan N; Verhoef J
    Int J Antimicrob Agents; 2000 Sep; 16(1):51-9. PubMed ID: 11185414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacterial genome engineering and synthetic biology: combating pathogens.
    Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
    BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobiotechnological Approaches Against Multidrug Resistant Bacterial Pathogens: An Update.
    Shaikh S; Shakil S; Abuzenadah AM; Rizvi SM; Roberts PM; Mushtaq G; Kamal MA
    Curr Drug Metab; 2015; 16(5):362-70. PubMed ID: 26419545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277
    [No Abstract]   [Full Text] [Related]  

  • 17. Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.
    O'Connell KM; Hodgkinson JT; Sore HF; Welch M; Salmond GP; Spring DR
    Angew Chem Int Ed Engl; 2013 Oct; 52(41):10706-33. PubMed ID: 24038605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging of bacterial resistance: an ongoing threat during and after the Syrian crisis.
    Battah B
    J Infect Dev Ctries; 2021 Mar; 15(2):179-184. PubMed ID: 33690197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-targeting by monotherapeutic antibacterials.
    Silver LL
    Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel target sites in bacteria for overcoming antibiotic resistance.
    Black MT; Hodgson J
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1528-38. PubMed ID: 15949866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.